Transplantation Using Bone Marrow from a (very) HLA Mismatched Unrelated Donor in the Setting of Post-Transplant Cyclophosphamide Is Feasible and Expands Access to Underserved Minorities

Bronwen E. Shaw, F. Javier Bolaños-Meade, Brent R. Logan et al.|Transplantation and Cellular Therapy|2020

Cited by 2